We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CRISPR-Cas9 Corrects Mutations in Muscular Dystrophy Patients' Cells

News   Jan 31, 2018 | Original Story by Ruairi J Mackenzie, Science Writer for Technology Networks

 
CRISPR-Cas9 Corrects Mutations in Muscular Dystrophy Patients' Cells

Members of the research team are pictured alongside a DMD patient and their family. Credit: UT Southwestern Medical Center

 
 
 

RELATED ARTICLES

Pursuing Hair-restoration Therapy – For Your Inner Ear

News

An NIH grant has been awarded to a group studying "crista" – inner-ear vestibular structures that are relatively under-studied, but are crucial for balance. The research group hopes that

READ MORE

Interrogation of Single Cells Taken One Step Further With ECCITE-Seq

News

A new technique called ECCITE-seq allows researchers to perform high-throughput measurements of multiple modalities of information from single cells.

READ MORE

Diversifying the Natural Building Blocks of Life

News

Using EBX reagents, researchers have converted the C-terminal carboxylic acid of peptides into a carbon-carbon triple bond - an alkyne (in chemical jargon a "decarboxylative alkynylation"). The alkyne moiety is a very valuable functional group that can be used to further modify the peptides.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE